Patent Assignment
Reel/Frame 019365/0596
Change of Name
Recorded: 2007-06-04
Pages: 3
Assignor
SAFESCIENCE, INC.
Executed: 2001-10-31
Assignee
GLYCOGENESYS, INC.
31 ST. JAMES AVE, BOSTON, MASSACHUSETTS, 02116
Covered Properties
(4)
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Patent:
6,645,946 →
Application:
09/818,596 →
Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments
Synthesis of galactomycin
Application:
60/235,141 →
5-Fluorouracil in a formulation for increased efficacy in treating tumors
Application:
60/317,092 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 31, 2001
From: KLYOSOV, ANATOLE; PLATT, DAVID
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 012420/0451 →
Assignment of Assignor's Interest
Jan 2, 2002
From: KLYOSOV, ANATOLE; PLATT, DAVID
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 012415/0699 →
Assignment of Claims
Jun 4, 2007
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 019365/0510 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019365/0568 →
Change of Name
Jun 4, 2007
From: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
To: PROSPECT PHARMACEUTICALS, INC.
Reel/Frame 019365/0633 →
Court Appointment of Trustee
Jun 4, 2007
From: GLYCOGENESYS, INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
Reel/Frame 019365/0501 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019375/0399 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019375/0429 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019390/0900 →
Change of Name
Jun 4, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 019365/0638 →
Security Agreement
Aug 26, 2009
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023134/0968 →
Change of Name
Oct 18, 2012
From: PRO-PHARMACEUTICALS, INC.
To: GALECTIN THERAPEUTICS INC.
Reel/Frame 029150/0654 →
Release of Security Interest
Sep 17, 2019
From: 10X FUND L.P.
To: GALECTIN THERAPEUTICS, INC.
Reel/Frame 050399/0679 →